These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10673715)

  • 1. Targeting adenovirus.
    Wickham TJ
    Gene Ther; 2000 Jan; 7(2):110-4. PubMed ID: 10673715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biophysical targeting of adenovirus vectors for gene therapy.
    Silman NJ; Fooks AR
    Curr Opin Mol Ther; 2000 Oct; 2(5):524-31. PubMed ID: 11249755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-targeted adenovirus vectors with dual specificity; binding specificities conferred by two different Affibody molecules in the fiber.
    Myhre S; Henning P; Friedman M; Ståhl S; Lindholm L; Magnusson MK
    Gene Ther; 2009 Feb; 16(2):252-61. PubMed ID: 18946496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances towards targetable adenovirus vectors for gene therapy.
    Einfeld DA; Roelvink PW
    Curr Opin Mol Ther; 2002 Oct; 4(5):444-51. PubMed ID: 12435045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of adenoviral vectors through a bispecific single-chain antibody.
    Haisma HJ; Grill J; Curiel DT; Hoogeland S; van Beusechem VW; Pinedo HM; Gerritsen WR
    Cancer Gene Ther; 2000 Jun; 7(6):901-4. PubMed ID: 10880021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and selection of targeted adenoviruses embodying optimized vector properties.
    Noureddini SC; Krendelshchikov A; Simonenko V; Hedley SJ; Douglas JT; Curiel DT; Korokhov N
    Virus Res; 2006 Mar; 116(1-2):185-95. PubMed ID: 16293334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors.
    Wesseling JG; Bosma PJ; Krasnykh V; Kashentseva EA; Blackwell JL; Reynolds PN; Li H; Parameshwar M; Vickers SM; Jaffee EM; Huibregtse K; Curiel DT; Dmitriev I
    Gene Ther; 2001 Jul; 8(13):969-76. PubMed ID: 11438831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant adenovirus vectors with knobless fibers for targeted gene transfer.
    van Beusechem VW; van Rijswijk AL; van Es HH; Haisma HJ; Pinedo HM; Gerritsen WR
    Gene Ther; 2000 Nov; 7(22):1940-6. PubMed ID: 11127582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of PEGylated adenovirus vector with targeting ligand.
    Eto Y; Yoshioka Y; Mukai Y; Okada N; Nakagawa S
    Int J Pharm; 2008 Apr; 354(1-2):3-8. PubMed ID: 17904316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy progress and prospects: adenoviral vectors.
    St George JA
    Gene Ther; 2003 Jul; 10(14):1135-41. PubMed ID: 12833122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic targeting of adenovirus vectors using a reovirus sigma1-based attachment protein.
    Schagen FH; Wensveen FM; Carette JE; Dermody TS; Gerritsen WR; van Beusechem VW
    Mol Ther; 2006 May; 13(5):997-1005. PubMed ID: 16515889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-mediated retargeting of recombinant adenovirus for gene transfer in vivo.
    Thoma C; Wieland S; Moradpour D; von Weizsäcker F; Offensperger S; Madon J; Blum HE; Offensperger WB
    Gene Ther; 2000 Jun; 7(12):1039-45. PubMed ID: 10871753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel adenoviral gene delivery system targeted against head and neck cancer.
    Li D; Guang W; Abuzeid WM; Roy S; Gao GP; Sauk JJ; O'Malley BW
    Laryngoscope; 2008 Apr; 118(4):650-8. PubMed ID: 18176343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual targeting of gene delivery by genetic modification of adenovirus serotype 5 fibers and cell-selective transcriptional control.
    Work LM; Ritchie N; Nicklin SA; Reynolds PN; Baker AH
    Gene Ther; 2004 Aug; 11(16):1296-300. PubMed ID: 15292916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinoma.
    Barker SD; Dmitriev IP; Nettelbeck DM; Liu B; Rivera AA; Alvarez RD; Curiel DT; Hemminki A
    Gene Ther; 2003 Jul; 10(14):1198-204. PubMed ID: 12833129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic targeting strategies for adenovirus.
    Noureddini SC; Curiel DT
    Mol Pharm; 2005; 2(5):341-7. PubMed ID: 16196486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral gene therapy strategies: from basic science to clinical application.
    Young LS; Searle PF; Onion D; Mautner V
    J Pathol; 2006 Jan; 208(2):299-318. PubMed ID: 16362990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct selection of targeted adenovirus vectors by random peptide display on the fiber knob.
    Miura Y; Yoshida K; Nishimoto T; Hatanaka K; Ohnami S; Asaka M; Douglas JT; Curiel DT; Yoshida T; Aoki K
    Gene Ther; 2007 Oct; 14(20):1448-60. PubMed ID: 17700705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional targeting of adenovirus vectors with the squamous cell carcinoma-specific antigen-2 promoter for selective apoptosis induction in lung cancer.
    Oshikiri T; Miyamoto M; Hiraoka K; Shichinohe T; Kawarada Y; Kato K; Suzuoki M; Nakakubo Y; Kondo S; Dosaka-Akita H; Kasahara N; Katoh H
    Cancer Gene Ther; 2006 Sep; 13(9):856-63. PubMed ID: 16710347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus 5 vector genetically re-targeted by an Affibody molecule with specificity for tumor antigen HER2/neu.
    Magnusson MK; Henning P; Myhre S; Wikman M; Uil TG; Friedman M; Andersson KM; Hong SS; Hoeben RC; Habib NA; Ståhl S; Boulanger P; Lindholm L
    Cancer Gene Ther; 2007 May; 14(5):468-79. PubMed ID: 17273181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.